Abstract:Neisseria meningitidis PglL belongs to a novel family of bacterial oligosaccharyltransferases (OTases) responsible for O-glycosylation of type IV pilins. Although members of this family are widespread among pathogenic bacteria, there is little known about their mechanism. Understanding the O-glycosylation process may uncover potential targets for therapeutic intervention, and can open new avenues for the exploitation of these pathways for biotechnological purposes. In this work, we demonstrate that PglL is able to transfer virtually any glycan from the undecaprenyl pyrophosphate (UndPP) carrier to pilin in engineered Escherichia coli and Salmonella cells. Surprisingly, PglL was also able to interfere with the peptidoglycan biosynthetic machinery and transfer peptidoglycan subunits to pilin. This represents a previously unknown post-translational modification in bacteria. Given the wide range of glycans transferred by PglL, we reasoned that substrate specificity of PglL lies in the lipid carrier. To test this hypothesis we developed an in vitro glycosylation system that employed purified PglL, pilin, and the lipid farnesyl pyrophosphate (FarPP) carrying a pentasaccharide that had been synthesized by successive chemical and enzymatic steps. Although FarPP has different stereochemistry and a significantly shorter aliphatic chain than the natural lipid substrate, the pentasaccharide was still transferred to pilin in our system. We propose that the primary roles of the lipid carrier during O-glycosylation are the translocation of the glycan into the periplasm, and the positioning of the pyrophosphate linker and glycan adjacent to PglL. The unique characteristics of PglL make this enzyme a promising tool for glycoengineering novel glycan-based vaccines and therapeutics.

Substrate-directed control of N-glycosylation in the endoplasmic reticulum calibrates signal reception at the cell-surface

Regulated N-glycosylation controls chaperone function and receptor trafficking

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells.

Extreme Substrate Promiscuity of the Neisseria Oligosaccharyl Transferase Involved in Protein O-Glycosylation

Imaging of protein-specific glycosylation by glycan metabolic tagging and in situ proximity ligation.

Site-to-site cross-talk in OST-B glycosylation of hCEACAM1-IgV

Proteome and Glycoproteome Analyses Reveal Regulation of Protein Glycosylation Site-Specific Occupancy and Lysosomal Hydrolase Maturation by N-Glycan-Dependent ER-Quality Control

Structural basis for coupling protein transport and N-glycosylation at the mammalian endoplasmic reticulum

Substrate O-glycosylation actively regulates extracellular proteolysis

Uncovering Eukaryotic Glycosylation Mechanism by Cryo-EM

Cryo-EM is uncovering the mechanism of eukaryotic protein N-glycosylation.

Oligosaccharyltransferase is involved in targeting to ER-associated degradation

O-GlcNAcylation of Core Components of the Translation Initiation Machinery Regulates Protein Synthesis.

Processing of N-glycans in the ER and Golgi influences the production of surface sialylated glycoRNA

Role Ofn-Linked Glycosylation in Biosynthesis, Trafficking, and Function of the Human Glucagon-Like Peptide 1 Receptor

N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease

Eukaryotic N-Glycosylation Occurs via the Membrane-anchored C-terminal Domain of the Stt3p Subunit of Oligosaccharyltransferase

Modulating Cell-Surface Receptor Signaling and Ion Channel Functions by In Situ Glycan Editing.

Acceptors stability modulates the efficiency of post-translational protein N-glycosylation

N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis